These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18782902)

  • 41. Relationships between the risk of cardiovascular disease in type 2 diabetes patients and both visit-to-visit variability and time-to-effect differences in blood pressure.
    Takao T; Kimura K; Suka M; Yanagisawa H; Kikuchi M; Kawazu S; Matsuyama Y
    J Diabetes Complications; 2015 Jul; 29(5):699-706. PubMed ID: 25861721
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Type 2 diabetes mellitus and cardiovascular risk factors: is comprehensive treatment required?].
    Nadal JF; Gutiérrez PC
    Med Clin (Barc); 2013 Sep; 141 Suppl 2():7-13. PubMed ID: 24444518
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Observed versus predicted cardiovascular events and all-cause death in HIV infection: a longitudinal cohort study.
    De Socio GV; Pucci G; Baldelli F; Schillaci G
    BMC Infect Dis; 2017 Jun; 17(1):414. PubMed ID: 28606059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Periodontal Treatment and the Risks of Cardiovascular Disease in Patients with Type 2 Diabetes: A Retrospective Cohort Study.
    Peng CH; Yang YS; Chan KC; Kornelius E; Chiou JY; Huang CN
    Intern Med; 2017; 56(9):1015-1021. PubMed ID: 28458305
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol.
    Durand M; Chartrand-Lefebvre C; Baril JG; Trottier S; Trottier B; Harris M; Walmsley S; Conway B; Wong A; Routy JP; Kovacs C; MacPherson PA; Monteith KM; Mansour S; Thanassoulis G; Abrahamowicz M; Zhu Z; Tsoukas C; Ancuta P; Bernard N; Tremblay CL;
    BMC Infect Dis; 2017 Sep; 17(1):611. PubMed ID: 28893184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data.
    Young JB; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Lafeuille MH; Duh MS; Bookhart B; Wysham CH
    Cardiovasc Diabetol; 2018 Aug; 17(1):118. PubMed ID: 30143045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low triglyceride as a marker for increased risk of cardiovascular diseases in patients with long-term type 2 diabetes: A cross-sectional survey in China.
    Ren Y; Ren Q; Lu J; Guo X; Huo X; Ji L; Yang X
    Diabetes Metab Res Rev; 2018 Feb; 34(2):. PubMed ID: 29124871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study.
    Echouffo-Tcheugui JB; Zhao S; Brock G; Matsouaka RA; Kline D; Joseph JJ
    Diabetes Care; 2019 Mar; 42(3):486-493. PubMed ID: 30659073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes.
    Wannamethee SG; Shaper AG; Walker M
    J Epidemiol Community Health; 2005 Feb; 59(2):134-9. PubMed ID: 15650145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study.
    Wei M; Gaskill SP; Haffner SM; Stern MP
    Diabetes Care; 1998 Jul; 21(7):1167-72. PubMed ID: 9653614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absolute risk of cardiovascular disease events, and blood pressure- and lipid-lowering therapy in Australia.
    Banks E; Crouch SR; Korda RJ; Stavreski B; Page K; Thurber KA; Grenfell R
    Med J Aust; 2016 May; 204(8):320. PubMed ID: 27125809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. One risk assessment tool for cardiovascular disease, type 2 diabetes, and chronic kidney disease.
    Alssema M; Newson RS; Bakker SJ; Stehouwer CD; Heymans MW; Nijpels G; Hillege HL; Hofman A; Witteman JC; Gansevoort RT; Dekker JM
    Diabetes Care; 2012 Apr; 35(4):741-8. PubMed ID: 22338109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes.
    Hoerger TJ; Ahmann AJ
    J Manag Care Pharm; 2008 Feb; 14(1 Suppl C):S2-14; quiz 15-6. PubMed ID: 18240890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up.
    Pongrac Barlovic D; Harjutsalo V; Gordin D; Kallio M; Forsblom C; King G; Groop PH;
    Diabetes Care; 2018 Dec; 41(12):2487-2494. PubMed ID: 30257963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gender-specific, Lifestyle-related Factors and 10-year Cardiovascular Disease Risk; the ATTICA and GREECS Cohort Studies.
    Kouvari M; Panagiotakos DB; Chrysohoou C; Georgousopoulou E; Notara V; Tousoulis D; Pitsavos C; Attica Greecs Studies Investigators
    Curr Vasc Pharmacol; 2019; 17(4):401-410. PubMed ID: 29886832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systematic review on urine albumin testing for early detection of diabetic complications.
    Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
    Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hypolipidemic and antihypertensive therapy in diabetic patients in the Czech Republic: notes on the VZP (General Health Insurance Company) Data].
    Šnejdrlová M; Češka R; Janíčková-Žďárská D; Honěk P; Dušek P; Pavlík T; Kvapil M
    Vnitr Lek; 2015 Nov; 61(11 Suppl 3):3S30-7. PubMed ID: 26652963
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between healthy diet and risk of cardiovascular disease among patients on drug therapies for secondary prevention: a prospective cohort study of 31 546 high-risk individuals from 40 countries.
    Dehghan M; Mente A; Teo KK; Gao P; Sleight P; Dagenais G; Avezum A; Probstfield JL; Dans T; Yusuf S;
    Circulation; 2012 Dec; 126(23):2705-12. PubMed ID: 23212996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Morbidity and mortality cardiovascular risk in dependence of type 2 diabetes duration].
    Gimeno Orna JA; Blasco Lamarca Y; Campos Gutierrez B; Molinero Herguedas E; Lou Arnal LM
    Clin Investig Arterioscler; 2014; 26(3):122-30. PubMed ID: 24461345
    [TBL] [Abstract][Full Text] [Related]  

  • 60. C-reactive protein and incident cardiovascular events among men with diabetes.
    Schulze MB; Rimm EB; Li T; Rifai N; Stampfer MJ; Hu FB
    Diabetes Care; 2004 Apr; 27(4):889-94. PubMed ID: 15047644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.